UCL is a registered charity, in accordance with the Charities Act 2006. The Higher Education Funding Council for England (HEFCE) acts on behalf of the Charity Commission as the university's principal regulator.
UCL receives funding from multiple sources to support our activities and research. In 2014, UCL was the university that attracted the most funding by value and made the highest number of successful applications to the first year of the European Union's Horizon 2020 programme, with 55 projects funded to a value of €73.2m.
Notable financial achievements:
UCL’s research grant spend was £397m in 2014-15, excluding both the UCL Institute of Education (which merged with UCL in 2014) and payments to third parties. This represents a 55.8% increase since 2009-10.
Income from enterprise-related activities as measured through the Higher
Education Business and Community Interaction (HEBCI) survey now shows
that £155m of UCL's operating (pre-merger) income is derived from
UCL Business (UCLB) has a mission to commercialise UCL’s research. Its
many high-profile transactions have included the creation of cancer
immunotherapy company Autolus, which attracted £30m in investment. This
was followed by a £25m investment into a new spin out, NewInc1354.
UCL has been the recipient of the UK’s second-largest Impact Acceleration Account from the Engineering and Physical Sciences Research Council (EPSRC), £4.47m over three years.
Competitively won research grants and contracts account for more than a third of UCL’s income.
|Research grants and contracts||£427.5m|
|Academic fees and support grants||£364.2m|
|Funding council grants||£187.4m|
|Other operating income||£194.5m|
|Endowment income and interest receivable||£6.1m|